EP 2941272 A1 20151111 - LEVOTHYROXINE FORMULATION WITH ACACIA
Title (en)
LEVOTHYROXINE FORMULATION WITH ACACIA
Title (de)
LEVOTHYROXIN-FORMULIERUNG MIT AKAZIE
Title (fr)
FORMULATION DE LÉVOTHYROXINE AVEC DE LA GOMME ARABIQUE
Publication
Application
Priority
US 2012071184 W 20121221
Abstract (en)
[origin: WO2014098887A1] A pharmaceutical composition comprising thyroxine, acacia, and an antioxidant selected from propyl gallate, butylated hydroxyanisol, and butylated hydroxytoluene is disclosed. The pharmaceutical composition has an improved shelf life. In one embodiment, the composition additionally comprises sucrose, microcrystalline cellulose, and mannitol. The pharmaceutical composition may be used for treating thyroid disorders by orally administering the composition to a patient in need thereof.
IPC 8 full level
A61K 47/10 (2006.01); A61K 9/20 (2006.01); A61K 31/198 (2006.01); A61K 47/14 (2006.01)
CPC (source: EP)
A61K 9/2054 (2013.01); A61K 31/198 (2013.01); A61K 47/10 (2013.01); A61K 47/14 (2013.01)
Citation (search report)
See references of WO 2014098887A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
DOCDB simple family (application)
US 2012071184 W 20121221; EP 12814094 A 20121221